{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T20:41:38Z","timestamp":1788381698925,"version":"build-2803163510"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,12,29]],"date-time":"2017-12-29T00:00:00Z","timestamp":1514505600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01DE023783-01A"],"award-info":[{"award-number":["R01DE023783-01A"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000072","name":"National Institute of Dental and Craniofacial Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000072","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007659","name":"Bayer Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000072","name":"National Institute of Dental and Craniofacial Research","doi-asserted-by":"publisher","award":["R01DE023783-01A"],"award-info":[{"award-number":["R01DE023783-01A"]}],"id":[{"id":"10.13039\/100000072","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.bone.2017.12.025","type":"journal-article","created":{"date-parts":[[2017,12,28]],"date-time":"2017-12-28T13:05:58Z","timestamp":1514466358000},"page":"79-88","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"special_numbering":"C","title":["Zoledronic acid increases the prevalence of medication-related osteonecrosis of the jaw in a dose dependent manner in rice rats (Oryzomys palustris) with localized periodontitis"],"prefix":"10.1016","volume":"108","author":[{"given":"J.G.","family":"Messer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4473-9918","authenticated-orcid":false,"given":"J.L.","family":"Mendieta Calle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.M.","family":"Jiron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.J.","family":"Castillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Van Poznak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Bhattacharyya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.B.","family":"Kimmel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8100-5839","authenticated-orcid":false,"given":"J.I.","family":"Aguirre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bone.2017.12.025_bb0005","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.1056\/NEJMp068157","article-title":"Osteonecrosis of the jaw\u2014do bisphosphonates pose a risk?","volume":"355","author":"Bilezikian","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bone.2017.12.025_bb0010","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1016\/j.joms.2004.09.004","article-title":"Bis-phossy jaw, phossy jaw, and the 21st century: bisphosphonate-associated complications of the jaws","volume":"62","author":"Hellstein","year":"2004","journal-title":"J. Oral Maxillofac. Surg."},{"key":"10.1016\/j.bone.2017.12.025_bb0015","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/S0278-2391(03)00720-1","article-title":"Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic","volume":"61","author":"Marx","year":"2003","journal-title":"J. Oral Maxillofac. Surg."},{"key":"10.1016\/j.bone.2017.12.025_bb0020","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1016\/j.joms.2005.07.010","article-title":"Bisphosphonate-induced exposed bone (osteonecrosis\/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment","volume":"63","author":"Marx","year":"2005","journal-title":"J. Oral Maxillofac. Surg."},{"key":"10.1016\/j.bone.2017.12.025_bb0025","doi-asserted-by":"crossref","first-page":"753","DOI":"10.7326\/0003-4819-144-10-200605160-00009","article-title":"Narrative [corrected] review: bisphosphonates and osteonecrosis of the jaws","volume":"144","author":"Woo","year":"2006","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.bone.2017.12.025_bb0030","first-page":"2035","article-title":"RANK ligand inhibition in bone metastatic cancer and risk of osteonecrosis of the jaw (ONJ): non bis in idem?","volume":"19","author":"Van den Wyngaert","year":"2011","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.bone.2017.12.025_bb0035","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S0140-6736(10)62344-6","article-title":"Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: a randomised, double-blind study","volume":"377","author":"Fizazi","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.bone.2017.12.025_bb0040","doi-asserted-by":"crossref","first-page":"5132","DOI":"10.1200\/JCO.2010.29.7101","article-title":"Denosumab compared with zoledronic acid for the treatment of bone metastases in patients with advanced breast cancer: a randomized, double-blind study","volume":"28","author":"Stopeck","year":"2010","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bone.2017.12.025_bb0045","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1080\/14740338.2016.1177021","article-title":"Osteonecrosis of jaw beyond antiresorptive (bone-targeted) agents: new horizons in oncology","volume":"15","author":"Fusco","year":"2016","journal-title":"Expert Opin. Drug Saf."},{"key":"10.1016\/j.bone.2017.12.025_bb0050","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1159\/000201931","article-title":"Combination of bisphosphonates and antiangiogenic factors induces osteonecrosis of the jaw more frequently than bisphosphonates alone","volume":"76","author":"Christodoulou","year":"2009","journal-title":"Oncology"},{"key":"10.1016\/j.bone.2017.12.025_bb0055","first-page":"385","article-title":"New non-bisphosphonate drugs that produce osteonecrosis of the jaws","volume":"13","author":"Ramirez","year":"2015","journal-title":"Oral Health Prev. Dent."},{"key":"10.1016\/j.bone.2017.12.025_bb0060","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1016\/j.joms.2014.04.031","article-title":"American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw\u20142014 update","volume":"72","author":"Ruggiero","year":"2014","journal-title":"J. Oral Maxillofac. Surg."},{"key":"10.1016\/j.bone.2017.12.025_bb0065","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s10549-011-1429-y","article-title":"Safety of zoledronic acid and incidence of osteonecrosis of the jaw (ONJ) during adjuvant therapy in a randomised phase III trial (AZURE: BIG 01-04) for women with stage II\/III breast cancer","volume":"127","author":"Coleman","year":"2011","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.bone.2017.12.025_bb0070","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1056\/NEJMoa1105195","article-title":"Breast-cancer adjuvant therapy with zoledronic acid","volume":"365","author":"Coleman","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bone.2017.12.025_bb0075","doi-asserted-by":"crossref","first-page":"2685","DOI":"10.1200\/JCO.2012.46.4792","article-title":"Osteonecrosis of the jaw and oral health-related quality of life after adjuvant zoledronic acid: an adjuvant zoledronic acid to reduce recurrence trial subprotocol (BIG01\/04)","volume":"31","author":"Rathbone","year":"2013","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bone.2017.12.025_bb0080","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.14219\/jada.archive.2010.0082","article-title":"The incidence of osteonecrosis of the jaw in patients receiving 5milligrams of zoledronic acid: data from the health outcomes and reduced incidence with zoledronic acid once yearly clinical trials program","volume":"141","author":"Grbic","year":"2010","journal-title":"J. Am. Dent. Assoc."},{"key":"10.1016\/j.bone.2017.12.025_bb0085","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.prosdent.2013.06.017","article-title":"Nonsurgical management of inflammatory periimplant disease caused by food impaction: a clinical report","volume":"111","author":"Bidra","year":"2014","journal-title":"J. Prosthet. Dent."},{"key":"10.1016\/j.bone.2017.12.025_bb0090","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1902\/jop.2015.150322","article-title":"Food impaction and periodontal\/peri-implant tissue conditions in relation to the embrasure dimensions between implant-supported fixed dental prostheses and adjacent teeth: a cross-sectional study","volume":"86","author":"Jeong","year":"2015","journal-title":"J. Periodontol."},{"key":"10.1016\/j.bone.2017.12.025_bb0095","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.jcms.2013.11.005","article-title":"Zoledronic acid - related osteonecrosis of the jaws. Experimental model with dental extractions in rats","volume":"42","author":"Barba-Recreo","year":"2014","journal-title":"J. Craniomaxillofac. Surg."},{"key":"10.1016\/j.bone.2017.12.025_bb0100","doi-asserted-by":"crossref","first-page":"280","DOI":"10.2353\/ajpath.2010.090592","article-title":"Bisphosphonates cause osteonecrosis of the jaw-like disease in mice","volume":"177","author":"Bi","year":"2010","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bone.2017.12.025_bb0105","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.oraloncology.2014.02.013","article-title":"Bisphosphonates inhibit bone remodeling in the jaw bones of rats and delay healing following tooth extractions","volume":"50","author":"Jabbour","year":"2014","journal-title":"Oral Oncol."},{"issue":"Suppl. 1","key":"10.1016\/j.bone.2017.12.025_bb0110","first-page":"S291","article-title":"Zoledronic acid delayed the wound healing of tooth extraction socket but failed to cause osteonecrosis of the jaw in mice","volume":"22","author":"Kobayashi","year":"2007","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2017.12.025_bb0115","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/hed.21422","article-title":"Association between bisphosphonates and jaw osteonecrosis: a study in Wistar rats","volume":"33","author":"Maahs","year":"2011","journal-title":"Head Neck"},{"key":"10.1016\/j.bone.2017.12.025_bb0120","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.bone.2016.06.011","article-title":"Osteonecrosis of the jaws (ONJ) in mice after extraction of teeth with periradicular disease","volume":"90","author":"Soundia","year":"2016","journal-title":"Bone"},{"key":"10.1016\/j.bone.2017.12.025_bb0125","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.jcms.2015.12.010","article-title":"Introducing a protocol to create bisphosphonate-related osteonecrosis of the jaw in rat animal model","volume":"44","author":"Zandi","year":"2016","journal-title":"J. Craniomaxillofac. Surg."},{"key":"10.1016\/j.bone.2017.12.025_bb0130","doi-asserted-by":"crossref","first-page":"17349","DOI":"10.1074\/jbc.M115.652305","article-title":"Osteonecrosis of the jaw developed in mice: disease variants regulated by gammadelta T cells in oral mucosa barrier immunity","volume":"290","author":"Park","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bone.2017.12.025_bb0135","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1016\/j.joen.2016.07.020","article-title":"Preexisting periapical inflammatory condition exacerbates tooth extraction-induced bisphosphonate-related osteonecrosis of the jaw lesions in mice","volume":"42","author":"Song","year":"2016","journal-title":"J. Endod."},{"key":"10.1016\/j.bone.2017.12.025_bb0140","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1359\/jbmr.0707onj","article-title":"Bisphosphonate-associated osteonecrosis of the jaw: report of a task force of the American Society for Bone and Mineral Research","volume":"22","author":"Khosla","year":"2007","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2017.12.025_bb0145","first-page":"2","article-title":"American Association of Oral and maxillofacial surgeons position paper on bisphosphonate-related osteonecrosis of the jaws\u20142009 update","volume":"67","author":"Ruggiero","year":"2009","journal-title":"J. Oral Maxillofac. Surg."},{"key":"10.1016\/j.bone.2017.12.025_bb0150","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1002\/jbmr.379","article-title":"Periodontal disease and bisphosphonates induce osteonecrosis of the jaws in the rat","volume":"26","author":"Aghaloo","year":"2011","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2017.12.025_bb0155","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1002\/jbmr.2097","article-title":"RANKL inhibitors induce osteonecrosis of the jaw in mice with periapical disease","volume":"29","author":"Aghaloo","year":"2014","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2017.12.025_bb0160","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1002\/jbmr.1669","article-title":"Oncologic doses of zoledronic acid induce osteonecrosis of the jaw-like lesions in rice rats (Oryzomys palustris) with periodontitis","volume":"27","author":"Aguirre","year":"2012","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2017.12.025_bb0165","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/clr.12502","article-title":"Role of periodontal disease in bisphosphonate-related osteonecrosis of the jaws in ovariectomized rats","volume":"27","author":"Li","year":"2016","journal-title":"Clin. Oral Implants Res."},{"key":"10.1016\/j.bone.2017.12.025_bb0170","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1016\/j.joen.2007.07.011","article-title":"Effect of an estrogen-deficient state and alendronate therapy on bone loss resulting from experimental periapical lesions in rats","volume":"33","author":"Xiong","year":"2007","journal-title":"J. Endod."},{"key":"10.1016\/j.bone.2017.12.025_bb0175","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1093\/jn\/63.3.325","article-title":"Periodontal disease in the rice rat. III. Survey of dietary influences","volume":"63","author":"Auskaps","year":"1957","journal-title":"J. Nutr."},{"key":"10.1016\/j.bone.2017.12.025_bb0180","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/j.1600-0765.1981.tb00976.x","article-title":"The progress of the periodontal syndrome in the rice rat. I. Morphometric and autoradiographic studies","volume":"16","author":"Gotcher","year":"1981","journal-title":"J. Periodontal Res."},{"key":"10.1016\/j.bone.2017.12.025_bb0185","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/0030-4220(56)90319-X","article-title":"Periodontal disease in the rice rat. I. Anatomic and histopathologic findings","volume":"9","author":"Gupta","year":"1956","journal-title":"Oral Surg. Oral Med. Oral Pathol."},{"key":"10.1016\/j.bone.2017.12.025_bb0190","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/0030-4220(77)90038-X","article-title":"The lack of pulpal pathosis in rice rats with the periodontal syndrome","volume":"44","author":"Hattler","year":"1977","journal-title":"Oral Surg. Oral Med. Oral Pathol."},{"key":"10.1016\/j.bone.2017.12.025_bb0195","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1111\/j.1600-0765.1980.tb00308.x","article-title":"Histological and ultrastructural characteristics of the periodontal syndrome in the rice rat. I. General light microscopic observations and ultrastructural observations of initial inflammatory changes","volume":"15","author":"Ryder","year":"1980","journal-title":"J. Periodontal Res."},{"key":"10.1016\/j.bone.2017.12.025_bb0200","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1111\/j.1600-0765.1981.tb00995.x","article-title":"The progress of the periodontal syndrome in the rice rat. II. The effects of a diphosphonate on the periodontium","volume":"16","author":"Gotcher","year":"1981","journal-title":"J. Periodontal Res."},{"key":"10.1016\/j.bone.2017.12.025_bb0205","first-page":"43","article-title":"Prevalence of food impaction-induced periodontitis in conventionally housed marsh rice rats (Oryzomys palustris)","volume":"67","author":"Messer","year":"2017","journal-title":"Comp. Med."},{"key":"10.1016\/j.bone.2017.12.025_bb0210","first-page":"319","article-title":"Body condition scoring: a rapid and accurate method for assessing health status in mice","volume":"49","author":"Ullman-Cullere","year":"1999","journal-title":"Lab. Anim. Sci."},{"key":"10.1016\/j.bone.2017.12.025_bb0215","series-title":"Casarett and Doull's Toxicology: The Basic Science of Poisons","author":"Klaassen","year":"2013"},{"key":"10.1016\/j.bone.2017.12.025_bb0220","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1359\/jbmr.071207","article-title":"Long-term protective effects of zoledronic acid on cancellous and cortical bone in the ovariectomized rat","volume":"23","author":"Gasser","year":"2008","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2017.12.025_bb0225","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1002\/jbmr.5650060405","article-title":"The bisphosphonate alendronate (MK-217) inhibits bone loss due to ovariectomy in rats","volume":"6","author":"Seedor","year":"1991","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2017.12.025_bb0230","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1158\/1078-0432.CCR-10-1614","article-title":"Effect of zoledronate on oral wound healing in rats","volume":"17","author":"Yamashita","year":"2011","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bone.2017.12.025_bb0235","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.bone.2013.05.013","article-title":"Chemotherapeutic and antiresorptive combination therapy suppressed lymphangiogenesis and induced osteonecrosis of the jaw-like lesions in mice","volume":"56","author":"Kuroshima","year":"2013","journal-title":"Bone"},{"key":"10.1016\/j.bone.2017.12.025_bb0240","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1359\/jbmr.2001.16.4.765","article-title":"Lasofoxifene (CP-336,156) protects against the age-related changes in bone mass, bone strength, and total serum cholesterol in intact aged male rats","volume":"16","author":"Ke","year":"2001","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2017.12.025_bb0245","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/j.1600-0714.2006.00391.x","article-title":"Osteonecrosis of the jaws in patients treated with bisphosphonates - histomorphologic analysis in comparison with infected osteoradionecrosis","volume":"35","author":"Hansen","year":"2006","journal-title":"J. Oral Pathol. Med."},{"key":"10.1016\/j.bone.2017.12.025_bb0250","first-page":"90","article-title":"Epidemiology and pathogenesis of osteonecrosis of the jaw","volume":"29","author":"Reid","year":"2011","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.bone.2017.12.025_bb0255","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.joms.2004.02.004","article-title":"Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases","volume":"62","author":"Ruggiero","year":"2004","journal-title":"J. Oral Maxillofac. Surg."},{"key":"10.1016\/j.bone.2017.12.025_bb0260","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/j.1749-6632.2010.05768.x","article-title":"Bisphosphonate-related osteonecrosis of the jaw: an overview","volume":"1218","author":"Ruggiero","year":"2011","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.bone.2017.12.025_bb0265","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.bone.2014.07.027","article-title":"Spontaneous osteonecrosis of the jaws in the maxilla of mice on antiresorptive treatment: a novel ONJ mouse model","volume":"68","author":"de Molon","year":"2014","journal-title":"Bone"},{"key":"10.1016\/j.bone.2017.12.025_bb0270","first-page":"7","article-title":"The causes and treatment strategies of molar food impaction after implant restoration","volume":"51","author":"Song","year":"2016","journal-title":"Zhonghua Kou Qiang Yi Xue Za Zhi"},{"key":"10.1016\/j.bone.2017.12.025_bb0275","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/j.mehy.2010.01.013","article-title":"Drug-induced gingival hyperplasia and scaffolds: they may be valuable for horizontal food impaction","volume":"74","author":"Du","year":"2010","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.bone.2017.12.025_bb0280","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/8756-3282(96)00182-2","article-title":"Comparison of the distribution of 3H-alendronate and 3H-etidronate in rat and mouse bones","volume":"19","author":"Masarachia","year":"1996","journal-title":"Bone"},{"key":"10.1016\/j.bone.2017.12.025_bb0285","first-page":"2394","article-title":"Approval summary for zoledronic acid for treatment of multiple myeloma and cancer bone metastases","volume":"9","author":"Ibrahim","year":"2003","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bone.2017.12.025_bb0290","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1038\/sj.bjc.6602551","article-title":"Zoledronic acid significantly improves pain scores and quality of life in breast cancer patients with bone metastases: a randomised, crossover study of community vs hospital bisphosphonate administration","volume":"92","author":"Wardley","year":"2005","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.bone.2017.12.025_bb0295","first-page":"307","article-title":"The clinical response on bone metastasis from breast and lung cancer during treatment with zoledronic acid is inversely correlated to skeletal related events (SRE)","volume":"26","author":"Facchini","year":"2007","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.bone.2017.12.025_bb0300","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1002\/ijc.24470","article-title":"The impact of zoledronic acid therapy in survival of lung cancer patients with bone metastasis","volume":"125","author":"Zarogoulidis","year":"2009","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bone.2017.12.025_bb0305","doi-asserted-by":"crossref","first-page":"2951","DOI":"10.1007\/s00198-011-1804-x","article-title":"Pathophysiology of atypical femoral fractures and osteonecrosis of the jaw","volume":"22","author":"Compston","year":"2011","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.bone.2017.12.025_bb0310","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1002\/jbmr.253","article-title":"Atypical subtrochanteric and diaphyseal femoral fractures: report of a task force of the American Society for Bone and Mineral Research","volume":"25","author":"Shane","year":"2010","journal-title":"J. Bone Miner. Res."}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328217304854?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328217304854?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T17:41:13Z","timestamp":1757612473000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S8756328217304854"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":62,"alternative-id":["S8756328217304854"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2017.12.025","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Zoledronic acid increases the prevalence of medication-related osteonecrosis of the jaw in a dose dependent manner in rice rats (Oryzomys palustris) with localized periodontitis","name":"articletitle","label":"Article Title"},{"value":"Bone","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bone.2017.12.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}